Carregando...

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors

In this analysis, we examined the efficacy, feasibility, and limitations of the application of mTOR inhibitors based on the individual molecular profiles of pretreated cancer patients after the failure of all standard treatments in the palliative setting. In this single-center, real-world analysis o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Hossein Taghizadeh, Agnieszka Maj-Hes, Gerald W. Prager, Leonhard Müllauer, Robert M. Mader
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
coleção:Cancers
Assuntos:
Acesso em linha:https://www.mdpi.com/2072-6694/14/8/1936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!